Tech & Property Buzz: Xiaomi’s Big Launch Spurs Broker Moves; XPENG Files Robot Patent; CATL Rumor Lifts Outlook; Hong Kong Property Shows Flickers of Turnaround
HK:03750.HK:CATL
Morgan Stanley (US:MS:Morgan Stanley) kept an upbeat view as Chinese media signaled CATL may debut an NCM811 battery pack next year, potentially boosting EREV capacity to ~80kWh from ~30–50kWh per unit; the bank noted the company has not confirmed the report.
HK:09868.HK:XPENG-W
XPENG (also US:XPEV:XPeng Inc.) was cited by Chinese media via Qichacha for a newly disclosed patent on a humanoid robot; the abstract highlights a mechanical arm design with a connecting bracket.
HK:01810.HK:XIAOMI-W
Citi (US:C:Citigroup Inc.) reiterated a Buy with a HKD66 target after calling the newly launched flagship Xiaomi 17 “impressive”; it added that Xiaomi Auto’s new customization service could lift EV ASPs and margins.
HK:01810.HK:XIAOMI-W
Morgan Stanley (US:MS:Morgan Stanley) set a HKD62 target following Thursday’s rollout of the Xiaomi 17 series—Xiaomi 17, 17 Pro, and 17 Pro Max—with Pro models featuring a new rear display; it flagged new smartphones and EV customization as potential positive catalysts.
HK:01810.HK:XIAOMI-W
Nomura (US:NMR:Nomura Holdings) kept a Neutral stance after Xiaomi’s 2H25 launch event showcasing the Xiaomi 17 line alongside Xiaomi Pad 8, Xiaomi TV, routers, smart speakers, and home appliances; it said updates on Xring chips and new EVs remain undisclosed.
HK:01810.HK:XIAOMI-W
Goldman Sachs (US:GS:The Goldman Sachs Group, Inc.) lifted its target to HKD66 and kept a Buy on XIAOMI-W, citing positive surprises from the fall product event.
US:UBS:UBS Group AG
UBS said Hong Kong’s office market may be nearing a turning point, expecting the decline in Grade A rents to narrow.
Hong Kong Housing Update
Hong Kong’s Rating and Valuation Department reported the August private residential price index rose 0.1% month-on-month, the third straight increase.
China & Hong Kong Market Flash: Xiaomi Slips Post-Launch, XPENG Pushes into Europe, Horizon Robotics Raises Cash; Biotech & Gaming in Focus
HK:2282.HK:MGM China Holdings
MGM CHINA strongly condemned impersonation of Pansy Ho used to spread false investment information and said it reserves legal rights.
HK:09868.HK:XPeng Inc.
XPENG-W said it is expanding into European markets including Switzerland, Austria and Hungary.
HK:01810.HK:Xiaomi Corp. (W)
XIAOMI-W fell about 3% in early trade despite unveiling the Xiaomi 17 and plans to invest at least RMB50 billion in chip development.
HK:0853.HK:MicroPort Scientific
MICROPORT briefly dived around 7% after reports a shareholder plans to offload a stake for up to HKD1.17 billion in cash.
HK:2269.HK:WuXi Biologics (Cayman) Inc.
WUXI BIO dropped over 3% as the U.S. moves to levy a 100% tariff on branded and patented drugs.
HK:9888.HK:Baidu, Inc. (SW)
BIDU-SW’s Apollo Go reportedly applied for autonomous vehicle testing in Kai Tak and Kowloon Bay.
HK:9660.HK:Horizon Robotics (W)
HORIZONROBOT-W opened over 5% lower and outlined plans to raise about HKD6.34 billion net via a top-up share placement at a 5.75% discount.
HK:9660.HK:Horizon Robotics (W)
Separately, HORIZONROBOT-W confirmed a top-up placement at a 5.75% discount to raise net proceeds of approximately HKD6.339 billion.
HK:2652.HK:CF PharmTech, Inc.
CF PHARMTECH began its Hong Kong IPO today with an entry fee of about HKD7,449.4.
HK:0005.HK:HSBC Holdings plc
HSBC HOLDINGS disclosed year-to-date buybacks of over 4.33 million shares totaling roughly USD462 million.
HK:3115.HK:Hang Seng Index (via iShares Core HSI ETF)
HSI opened 212 points lower as XIAOMI-W fell and pharmaceutical names weighed.
Thank you
